TuesdayJun 07, 2022 12:51 pm

QualityStocksNewsBreaks – Why Odyssey Health Inc. (ODYY) Is ‘One to Watch’

Odyssey Health (OTC: ODYY) is a medical technology company focused on developing lifesaving products that offer technological and clinical advantages over current standards of care. Guided by a senior management team with significant experience relating to refining acquired technologies, building commercial systems, and forging strategic partnerships, the company boasts a diverse development portfolio spanning both pharmaceutical candidates and medical devices. “Odyssey has two pharmaceutical products in development: PRV-002 and PRV-001. PRV-002 is a novel compound for the treatment of concussion, which currently has no FDA-approved drug. In pre-clinical studies, PRV-002 has been shown to significantly improve both neuroscore and memory…

Continue Reading

TuesdayJun 07, 2022 11:14 am

QualityStocksNewsBreaks – SPYR Technologies (SPYR) Announces FCC Approval, PTCRB Certification of GeoTraq’s Tracker Module

SPYR (OTCQB: SPYR), a technology company, today announced that its subsidiary GeoTraq’s Tracker Module (“GT-TM100”) is FCC approved and ready for the market. According to the update, the GT-TM100 has successfully completed certification testing required by the PCS Type Certification Review Board (“PTCRB”) and is in compliance with FCC Part 15 Subpart B, Class B (“sDoC”) performance specifications. The PTCRB program provides confidence that devices perform optimally on mobile wireless networks and conform with global standards. “The Tracker Module is a complete, ‘self-contained’ device that can easily be inserted into any device, asset or package to connect it to the…

Continue Reading

TuesdayJun 07, 2022 11:00 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Acquisition of Entheon Biomedical’s DMT Clinical Study

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has entered an agreement to acquire the largest phase 1 DMT study conducted to date. The acquisition, conducted through Cybin IRL Limited, a wholly owned subsidiary of Cybin, is expected to accelerate Cybin’s CYB004 program timeline by an estimated nine months; CYB004 is Cybin’s proprietary deuterated DMT molecule designed for the potential treatment of anxiety disorders.. The phase 1 N,N-dimethyltryptamine (“DMT”) study is focused on evaluating pharmacokinetics/pharmacodynamics of DMT currently underway and is expected to significantly impact the clinical path forward. Renamed CYB004-E, the phase 1 EBRX-101…

Continue Reading

TuesdayJun 07, 2022 10:30 am

NCFA’s Flagship Annual Fintech Summer Mixer and Networking Event to be held on July 14th in Toronto’s Trendy Queen West

Date: Thursday, 14th July 2022Venue: SPACES, 7th Floor Loft and Rooftop Patio, 180 John Street, Toronto, ON M5T 1X5 The National Crowdfunding and Fintech Association of Canada (“NCFA”) invites investors, stealth and emerging start-ups, scale-ups, and industry experts from the growing fintech, blockchain, crypto, AI, digital finance and open banking, sustainable finance, crowdfunding, payments, digital identity, and alternative investment sectors to the 6th Annual Fintech & Funding Summer Kickoff and Rooftop Patio Mixer (“NCFA Summer Mixer”) on July 14, 2022.  The event is being hosted in association with leading members of Canada’s Fintech and Funding community, including Liquid Avatar Technologies,…

Continue Reading

TuesdayJun 07, 2022 10:07 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $5M Direct, Private Placement Offerings

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has closed on its registered direct offering and concurrent private placement with a single healthcare-focused institutional investor; the offerings were priced at-the-market under Nasdaq rules. According to the announcement, for the registered direct offering, INM issued 4,079,256 common shares at a purchase price of $0.858 per share (or prefunded warrant in lieu thereof). For the concurrent private placement, InMed issued and sold to the investor 1,748,250 common shares (or prefunded warrant in lieu thereto); those shares were offered at the same purchase price as…

Continue Reading

TuesdayJun 07, 2022 9:45 am

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Adds New Member to Board; Releases New Lightning Network Node in South Korea

The Lightning Network continues to grow despite the current situation within the Bitcoin market – registering a high capacity of 3,915.34 BTC LQwD has released two more nodes on the Lightning Network, creating a network reach that includes Canada, South Korea, US, Ireland, India, Germany, Singapore, Sweden, Indonesia, Italy, France, and England The company has appointed Peter Loretto to the board to replace Dean Sutton LQwD is a part of Visa's Fintech Fast Track program, leveraging Visa's services for global reach and capabilities The cryptocurrency market was valued at US $1.6 billion in 2021 and is expected to grow to…

Continue Reading

TuesdayJun 07, 2022 9:00 am

Correlate Infrastructure Partners Inc. (CIPI) Applies for Uplisting to the NASDAQ Exchange, Aims at Achieving Increased Investor Awareness

Correlate looks to enjoy greater access to analyst coverage, and increased investor awareness should its application to uplist to the Nasdaq Exchange go through The company continues to execute its publicly announced acquisition strategy, the first step in pursuit of approval for uplisting Its management is confident that this will improve the company’s visibility, allowing it to showcase its achievements to a growing pool of investors This application comes when green energy alternatives are under threat, with solar deployment estimated to drop by 50% in 2022 in the U.S. On April 1, 2022, Correlate Infrastructure Partners (OTCQB: CIPI) announced the…

Continue Reading

MondayJun 06, 2022 3:32 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Earns “In-Process” Rating from US Government FedRAMP Program

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, announced that as part of its efforts to pursue Authority to Authorize (“ATO”) in the Federal Risk and Authorization Management Program (“FedRAMP”), the company achieved “In-Process” status. A government-wide program that promotes the adoption of secure cloud services across the federal government, FedRAMP provides a standardized approach to security assessment and authorization, and provides continuous monitoring for cloud products and services. Knightscope has been working to design a secure, hardened environment specifically to support government clients; as part of those efforts, the company built…

Continue Reading

MondayJun 06, 2022 3:10 pm

QualityStocksNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Immune Monitoring Platform ‘Is the Right Technology at the Right Time’

Aditxt (NASDAQ: ADTX) recently entered into a multi-year partnership with Guthy-Renker LLC- affiliated GRS. The partnership focuses on building awareness and visibility among consumers and health care providers for the proprietary AditxtScore(TM) Immune Monitoring Platform. “AditxtScore is the right technology at the right time. Our first application, AditxtScore for COVID-19, delivers timely reports on vulnerability and immune status to SARS-CoV-2 and its known variants, giving consumers and their physicians the data they need to make informed health decisions for themselves and their families,” Aditxt CEO and Co-Founder Amro Albanna was quoted in a recent article. Albanna added that the company’s…

Continue Reading

MondayJun 06, 2022 2:13 pm

QualityStocksNewsBreaks – Advanced Container Technologies Inc. (ACTX), Growpods Spotlighted in Borgen Magazine Article

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, along with related equipment and supplies, were featured in an article published in Borgen magazine. The article, titled “How GrowPods Are Aiding Global Food Security,” notes that ACTX’s GrowPods “have the potential to help achieve global food security.” Noting that the consequences of global food insecurity are enormous, the article reports that Advanced Container Technologies and the innovative GrowPods may help solve the issue of global food shortages. Because the modular hydroponic farms can be located anywhere and provide an easily, accessible way to grow…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered